Anti-DR5 antibody [EPR22276]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(3 Publications)
Rabbit Recombinant Monoclonal DR5 antibody. Suitable for IP, WB, IHC-P and reacts with Human samples. Cited in 3 publications.
View Alternative Names
CD262, DR5, KILLER, TRAILR2, TRICK2, ZTNFR9, UNQ160/PRO186, TNFRSF10B, Tumor necrosis factor receptor superfamily member 10B, Death receptor 5, TNF-related apoptosis-inducing ligand receptor 2, TRAIL receptor 2, TRAIL-R2
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-DR5 antibody [EPR22276] (AB230969)
Immunohistochemical analysis of paraffin-embedded human colon cancer tissue labeling DR5 with ab230969 at 1/1000 dilution, followed by a ready to use Goat Anti-Rabbit IgG H&L (HRP). Membranous and cytoplasmic staining in human colon cancer cells (PMID : 23284732) is observed. Counterstained with hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is a ready to use Goat Anti-Rabbit IgG H&L (HRP).
Perform heat mediated antigen retrieval using ab93684 (Tris/EDTA buffer, pH 9.0).
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-DR5 antibody [EPR22276] (AB230969)
Immunohistochemical analysis of paraffin-embedded human endometrium tissue labeling DR5 with ab230969 at 1/2000 dilution, followed by a ready to use Goat Anti-Rabbit IgG H&L (HRP). Cytoplasmic staining in endothelial cells of human endometrium (PMID : 22789540, 12874246, 15987601) is observed. Counterstained with hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is a ready to use Goat Anti-Rabbit IgG H&L (HRP).
Perform heat mediated antigen retrieval using ab93684 (Tris/EDTA buffer, pH 9.0).
- IP
Supplier Data
Immunoprecipitation - Anti-DR5 antibody [EPR22276] (AB230969)
DR5 was immunoprecipitated from 0.35 mg U-87 MG (human glioblastoma-astrocytoma epithelial cell) whole cell lysate with ab230969 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab230969 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/5000 dilution.
Lane 1 : U-87 MG whole cell lysate 10 μg (Input).
Lane 2 : ab230969 IP in U-87 MG whole cell lysate.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab230969 in U-87 MG whole cell lysate.
Blocking/Dilution buffer : 5% NFDM/TBST.
Exposure time : 20 seconds.
The molecular weight observed is consistent with what has been described in the literature. The 40kDa band is a cleaved form (PMID : 20515924, 16297203).
All lanes:
Immunoprecipitation - Anti-DR5 antibody [EPR22276] (ab230969)
Predicted band size: 47 kDa
Observed band size: 40 kDa,48 kDa
false
- WB
Lab
Western blot - Anti-DR5 antibody [EPR22276] (AB230969)
The molecular weight observed is consistent with what has been described in the literature, the 40kDa band is a cleaved form (PMID : 20515924, 16297203).
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-DR5 antibody [EPR22276] (ab230969) at 1/1000 dilution
Lane 1:
Untreated HCT116 (human colorectal carcinoma epithelial cell), whole cell lysate at 20 µg
Lane 2:
HCT116 treated with 0.5 μM doxorubicin (<a href='/en-us/products/biochemicals/doxorubicin-hydrochloride-topoisomerase-ii-inhibitor-ab120629'>ab120629</a>) for 24 hours, whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 47 kDa
false
Exposure time: 3min
- WB
Supplier Data
Western blot - Anti-DR5 antibody [EPR22276] (AB230969)
The molecular weight observed is consistent with what has been described in the literature. The 40kDa band is a cleaved form (PMID : 20515924, 16297203).
Blocking/Dilution buffer : 5% NFDM/TBST.
Exposure times : Lanes 1 : 3 minutes; Lanes 2-3 : 59 seconds.
All lanes:
Western blot - Anti-DR5 antibody [EPR22276] (ab230969) at 1/1000 dilution
Lane 1:
HepG2 (human hepatocellular carcinoma epithelial cell), whole cell lysate at 20 µg
Lane 2:
HT-1080 (human fibrosarcoma epithelial cell), whole cell lysate at 20 µg
Lane 3:
U-87 MG (human glioblastoma-astrocytoma epithelial cell), whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 47 kDa
false
Related conjugates and formulations (1)
-
Anti-DR5 antibody [EPR22276] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
DR5 plays a significant role in the regulation of apoptosis particularly in cancer cells. It is a component of the TRAIL receptor complex which includes several other death receptors like DR4. This complex formation allows DR5 to mediate apoptotic signals more efficiently. By controlling apoptosis DR5 helps maintain tissue homeostasis and prevents abnormal cell proliferation.
Pathways
DR5 is an important part of the TRAIL signaling pathway and the extrinsic apoptosis pathway. It connects with proteins like FADD and Caspase-8 essential in the apoptotic signaling cascade. By interacting with these proteins DR5 drives the progression of the apoptotic signal ensuring the removal of dysfunctional cells. Such pathways are vital for restraining tumor development and progression.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (3)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 16:6327 PubMed40645931
2025
Applications
Unspecified application
Species
Unspecified reactive species
MedComm 5:e457 PubMed38222315
2024
Applications
Unspecified application
Species
Unspecified reactive species
Environmental toxicology 35:1100-1113 PubMed32506763
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com